SCHEMBL2336735

SCHEMBL2336735

NC(=O)NNc1cccc2cccnc12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.72
KMT2A Q03164 3/20 0.72
MAPT P10636 3/20 0.72
ALDH1A1 P00352 3/20 0.72
L3MBTL1 Q9Y468 2/20 0.72
NPSR1 Q6W5P4 1/20 0.72
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
TDP1 Q9NUW8 3/20 0.55
POLB P06746 2/20 0.55
PARP1 P09874 1/20 0.54
KDR P35968 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.52
KDM4E B2RXH2 2/20 0.51
HDAC6 Q9UBN7 1/20 0.51
RECQL P46063 1/20 0.51
CASP3 P42574 1/20 0.51
SENP8 Q96LD8 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
HTT P42858 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3549883 0.83 CYP1A2 (0.71) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL17681655 0.81 MEN1 (0.68) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL28325304 0.75 MEN1 (0.52) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL1695444 0.75 KDR (0.71) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL29851236 0.75 KDR (0.71) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL18768618 0.74 TDP1 (0.58) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL30882803 0.74 KMT2A (0.63) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL1753903 0.73 TDP1 (0.79) MEN1KMT2AMAPTALDH1A1NPSR1
SCHEMBL4512999 0.73 CYP1A2 (1.00) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL3909349 0.73 TDP1 (0.67) MEN1KMT2AMAPTALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160067257-A1 SCREENING METHOD AND COMPOUNDS FOR MODULATING TELOMERASE ACTIVITY THE WISTAR INSTITUTE (US) 2016-03-10 US disclosed
US-9234230-B2 Screening method and compounds for modulating telomerase activity THE WISTAR INSTITUTE (US) 2016-01-12 US disclosed
US-8518940-B2 FP-pocket-binding effectors and methods for using the same to modulate telomerase activity THE WISTAR INSTITUTE (US) 2013-08-27 US disclosed
US-20120309759-A1 Screening Method and Compounds for Modulating Telomerase Activity THE WISTAR INSTITUTE (US) 2012-12-06 US disclosed
WO-2011097600-A1 SCREENING METHOD AND COMPOUNDS FOR MODULATING TELOMERASE ACTIVITY THE WISTAR INSTITUTE (US) 2011-08-11 WO disclosed
US-20100158798-A1 FP-Pocket-Binding Effectors and Methods for Using the Same to Modulate Telomerase Activity THE WISTAR INSTITUTE 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309759-A1 Screening Method and Compounds for Modulating Telomerase Activity TERT, TERB1, TERF2 MEN1 3807/4885KMT2A 2921/4885MAPT 2733/4885
US-20100158798-A1 FP-Pocket-Binding Effectors and Methods for Using the Same to Modulate Telomerase Activity TERF2IP, TERF2, TERT MEN1 2732/4885KMT2A 2483/4885MAPT 3047/4885
US-20160067257-A1 SCREENING METHOD AND COMPOUNDS FOR MODULATING TELOMERASE ACTIVITY TERT, TERB1, TERF2 MEN1 3807/4885KMT2A 2921/4885MAPT 2733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.